# Patient Survey: Hair and Nail Health in ME/CFS

**Purpose:** Test the prediction that hair and nail growth remain preserved in ME/CFS despite severe energy dysfunction in CNS-dependent systems.

**Hypothesis:** The selective energy dysfunction hypothesis predicts that truly autonomous peripheral processes (hair follicle cycling, nail growth) that operate independently of CNS coordination should be preserved even in severe ME/CFS.

**Date Created:** 2026-02-04
**Status:** Draft - Ready for validation

---

## Survey Overview

### Target Population

- **Primary cohort:** ME/CFS patients meeting ICC or CCC criteria
- **Severity range:** Mild to very severe (all functional capacity levels)
- **Comparison groups:**
  - Healthy matched controls
  - Other chronic illnesses (depression, autoimmune disease) as disease controls

### Survey Instrument Design

**Estimated completion time:** 15-20 minutes
**Format:** Online questionnaire with optional photos
**Validation:** Pilot with 10-20 patients before full deployment

---

## Survey Sections

### Section 1: Demographics & Disease Characteristics

#### Q1: Basic Information
- Age: _____
- Sex assigned at birth: [ ] Male [ ] Female [ ] Intersex
- Gender identity: [ ] Male [ ] Female [ ] Non-binary [ ] Other [ ] Prefer not to say
- Ethnicity/Race: [Multiple selection allowed]

#### Q2: ME/CFS Diagnosis
- Year of ME/CFS onset: _____
- Diagnostic criteria met: [ ] ICC [ ] CCC [ ] Fukuda [ ] IOM [ ] Other: _____
- Diagnosing physician specialty: [ ] ME/CFS specialist [ ] General practitioner [ ] Other: _____

#### Q3: Current Severity (Bell Scale)
[ ] 100 - No symptoms at rest; no symptoms with exercise; normal overall activity; able to work full time without difficulty
[ ] 90 - No symptoms at rest; mild symptoms with activity; normal overall activity; able to work full time without difficulty
[ ] 80 - Mild symptoms at rest; symptoms worsened by exertion; minimal activity restriction; able to work full time with difficulty
[ ] 70 - Mild symptoms at rest; some daily activity limitation; overall functioning close to 90% except at times of exertion
[ ] 60 - Mild to moderate symptoms at rest; daily activity limitation clearly noted; overall functioning 70-90%; unable to work full time in employment requiring physical labor
[ ] 50 - Moderate symptoms at rest; moderate to significant activity restriction; overall functioning 70% reduced from premorbid level; unable to perform strenuous duties but able to perform light duty or desk work 4-5 hours a day
[ ] 40 - Moderate symptoms at rest; moderate to significant activity restriction; overall functioning 50-70% of expected; not confined to house; unable to perform strenuous duties; able to work sitting down at home 3-4 hours a day
[ ] 30 - Moderate to severe symptoms at rest; severe activity restriction; overall functioning 50% of expected; usually confined to house; unable to perform any strenuous tasks; able to perform desk work 2-3 hours a day
[ ] 20 - Moderate to severe symptoms at rest; unable to perform strenuous activity; overall functioning 30-50%; unable to leave house except rarely; confined to bed most of day; unable to concentrate for more than 1 hour a day
[ ] 10 - Severe symptoms at rest; bedridden the majority of the time; no travel outside of the house; marked cognitive symptoms preventing concentration
[ ] 0 - Severe symptoms on a continuous basis; bedridden constantly; unable to care for self

#### Q4: Disease Duration in Current Severity State
- How long at current severity? [ ] <6 months [ ] 6-12 months [ ] 1-2 years [ ] 2-5 years [ ] >5 years

#### Q5: Comorbid Conditions
Check all that apply:
[ ] Hypothyroidism
[ ] Hyperthyroidism
[ ] POTS/Dysautonomia
[ ] Ehlers-Danlos Syndrome
[ ] Mast Cell Activation Syndrome
[ ] Autoimmune disease (specify): _____
[ ] Depression (diagnosed)
[ ] Anxiety disorder (diagnosed)
[ ] Eating disorder (current or past)
[ ] Malnutrition/severe weight loss
[ ] Chemotherapy (past 5 years)
[ ] Other chronic illness: _____

---

### Section 2: Hair Health Assessment

#### Q6: Hair Growth Rate (Subjective)

Compared to before ME/CFS onset (or to age-matched peers if onset was in childhood):

**Scalp hair growth rate:**
[ ] Much faster than before/expected
[ ] Somewhat faster than before/expected
[ ] About the same as before/expected
[ ] Somewhat slower than before/expected
[ ] Much slower than before/expected
[ ] Don't know / Can't recall

**Objective measurement (if available):**
- Have you measured hair growth rate? [ ] Yes [ ] No
- If yes, current rate: _____ cm/month
- If known, pre-illness rate: _____ cm/month

#### Q7: Hair Thickness and Quality

Compared to before ME/CFS:

**Hair thickness:**
[ ] Much thicker
[ ] Somewhat thicker
[ ] About the same
[ ] Somewhat thinner
[ ] Much thinner
[ ] Don't know

**Hair texture:**
[ ] Much coarser/stronger
[ ] Somewhat coarser/stronger
[ ] About the same
[ ] Somewhat finer/weaker
[ ] Much finer/weaker
[ ] Changed in other way (describe): _____

**Hair shine/health appearance:**
[ ] Much healthier looking
[ ] Somewhat healthier looking
[ ] About the same
[ ] Somewhat duller/unhealthier looking
[ ] Much duller/unhealthier looking

#### Q8: Hair Loss Pattern

**Overall hair density:**
[ ] Increased density (more hair)
[ ] No change in density
[ ] Mild diffuse thinning
[ ] Moderate diffuse thinning
[ ] Severe diffuse thinning
[ ] Patchy hair loss (describe pattern): _____
[ ] Other pattern: _____

**Timing of any hair loss:**
[ ] No hair loss
[ ] Occurred at ME/CFS onset, then stabilized
[ ] Occurred months/years after onset
[ ] Progressive throughout illness
[ ] Cyclical (comes and goes)

**If hair loss occurred, was it:**
[ ] N/A - no hair loss
[ ] Similar pattern to other family members (genetic)
[ ] Diagnosed as alopecia areata (autoimmune)
[ ] Diagnosed as telogen effluvium (stress-related)
[ ] Diagnosed as androgenic alopecia (hormonal)
[ ] Unknown cause

#### Q9: Hair Growth During Severe Crashes

During your worst ME/CFS symptom periods (severe PEM or crashes):

**Hair growth:**
[ ] Never experienced severe crashes
[ ] Seems to slow down noticeably
[ ] Seems about the same as usual
[ ] Don't know / Haven't noticed

**Hair quality during crashes:**
[ ] Never experienced severe crashes
[ ] Gets noticeably worse (dull, brittle)
[ ] Stays about the same
[ ] Don't know / Haven't noticed

#### Q10: Facial/Body Hair (if applicable)

Compared to before ME/CFS:

**Facial hair growth rate (if you typically have facial hair):**
[ ] N/A
[ ] Faster than before
[ ] About the same
[ ] Slower than before

**Body hair growth rate:**
[ ] Faster than before
[ ] About the same
[ ] Slower than before
[ ] Don't know

---

### Section 3: Nail Health Assessment

#### Q11: Fingernail Growth Rate

Compared to before ME/CFS onset:

**Growth rate:**
[ ] Much faster than before
[ ] Somewhat faster than before
[ ] About the same as before
[ ] Somewhat slower than before
[ ] Much slower than before
[ ] Don't know

**Objective measurement (if available):**
- Have you measured nail growth? [ ] Yes [ ] No
- If yes, current rate: _____ mm/month
- If known, pre-illness rate: _____ mm/month

#### Q12: Fingernail Quality

Compared to before ME/CFS:

**Nail strength:**
[ ] Much stronger (less breaking)
[ ] Somewhat stronger
[ ] About the same
[ ] Somewhat weaker (more breaking)
[ ] Much weaker (very brittle)

**Nail thickness:**
[ ] Much thicker
[ ] Somewhat thicker
[ ] About the same
[ ] Somewhat thinner
[ ] Much thinner

**Nail surface:**
[ ] Smooth (better than before)
[ ] Smooth (same as before)
[ ] Mild ridges (vertical or horizontal)
[ ] Moderate ridges
[ ] Severe ridges or pitting
[ ] Other abnormalities (describe): _____

#### Q13: Nail Appearance Features

Check all that apply:
[ ] White spots/lines (leukonychia)
[ ] Horizontal ridges (Beau's lines)
[ ] Vertical ridges
[ ] Spooning (koilonychia)
[ ] Clubbing
[ ] Yellow discoloration
[ ] Separation from nail bed (onycholysis)
[ ] None of the above - nails appear normal

**If abnormalities present, timing:**
[ ] N/A - no abnormalities
[ ] Appeared at ME/CFS onset
[ ] Appeared months/years after onset
[ ] Pre-existed ME/CFS
[ ] Cyclical (come and go)

#### Q14: Toenail Health

Compared to fingernails:

**Toenail growth/quality:**
[ ] Similar to fingernails (both normal or both abnormal)
[ ] Toenails more affected than fingernails
[ ] Fingernails more affected than toenails
[ ] Both severely affected
[ ] Both normal/healthy

---

### Section 4: Correlation with Disease Activity

#### Q15: Hair/Nail Changes vs ME/CFS Severity

Over the course of your illness, as overall ME/CFS severity changed:

**Hair health:**
[ ] Improved when ME/CFS improved, worsened when ME/CFS worsened (correlated)
[ ] Stayed consistent regardless of ME/CFS severity (uncorrelated)
[ ] Changed but not clearly related to ME/CFS severity
[ ] Don't know / Can't tell

**Nail health:**
[ ] Improved when ME/CFS improved, worsened when ME/CFS worsened (correlated)
[ ] Stayed consistent regardless of ME/CFS severity (uncorrelated)
[ ] Changed but not clearly related to ME/CFS severity
[ ] Don't know / Can't tell

#### Q16: Comparison to Other Body Functions

How does your hair/nail health compare to other body systems?

**Hair growth compared to:**

*Muscle strength:* [ ] Hair better preserved [ ] Both equally affected [ ] Muscle better preserved

*Cognitive function:* [ ] Hair better preserved [ ] Both equally affected [ ] Cognition better preserved

*Exercise capacity:* [ ] Hair better preserved [ ] Both equally affected [ ] Exercise better preserved

*Immune function:* [ ] Hair better preserved [ ] Both equally affected [ ] Immune better preserved

**Nail growth compared to:**

*Wound healing:* [ ] Nails better [ ] Both similar [ ] Healing better

*Skin health:* [ ] Nails better [ ] Both similar [ ] Skin better

---

### Section 5: Confounding Factors

#### Q17: Nutritional Status

**Dietary intake:**
[ ] Normal, varied diet
[ ] Some restrictions but adequate nutrition
[ ] Moderate nutritional deficiencies (documented)
[ ] Severe nutritional deficiencies or malnutrition
[ ] Eating disorder affecting intake

**Protein intake:**
[ ] Adequate (>0.8g/kg/day)
[ ] Borderline
[ ] Insufficient (<0.6g/kg/day)
[ ] Don't know

**Known deficiencies (documented by testing):**
[ ] Iron deficiency / anemia
[ ] Vitamin D deficiency
[ ] B12 deficiency
[ ] Biotin deficiency
[ ] Zinc deficiency
[ ] Other: _____
[ ] None known

#### Q18: Medications and Supplements

**Medications that may affect hair/nails:**
[ ] Thyroid medication (levothyroxine, etc.)
[ ] Biotin supplements
[ ] Hair/skin/nail supplements
[ ] Chemotherapy (past 2 years)
[ ] Immunosuppressants
[ ] Corticosteroids (regular use)
[ ] Beta blockers
[ ] Other hormones: _____

**Duration on biotin or hair/nail supplements:**
[ ] Not taking
[ ] <3 months
[ ] 3-6 months
[ ] 6-12 months
[ ] >1 year

#### Q19: Grooming Practices

**Hair care:**
[ ] Minimal manipulation (natural, rarely styled)
[ ] Moderate (regular washing, occasional styling)
[ ] Intensive (frequent heat styling, chemical treatments)

**Chemical treatments in past year:**
[ ] None
[ ] Hair dye
[ ] Permanent/relaxer
[ ] Bleach
[ ] Other: _____

**Nail care:**
[ ] Natural nails, minimal treatment
[ ] Regular polish
[ ] Gel/shellac manicures
[ ] Acrylic/artificial nails
[ ] Other: _____

#### Q20: Age and Hormonal Factors

**Current age category:**
[ ] <20 [ ] 20-29 [ ] 30-39 [ ] 40-49 [ ] 50-59 [ ] 60-69 [ ] 70+

**Menopausal status (if applicable):**
[ ] N/A
[ ] Premenopausal
[ ] Perimenopausal
[ ] Postmenopausal
[ ] Surgical menopause

**Hormonal treatments:**
[ ] None
[ ] Oral contraceptives
[ ] Hormone replacement therapy
[ ] Testosterone therapy
[ ] Other: _____

---

### Section 6: Free Response

#### Q21: Additional Observations

Please describe any patterns you've noticed regarding your hair or nail health and ME/CFS:

[Free text box - 500 characters]

#### Q22: Photo Upload (Optional)

If comfortable, please upload photos of:
- Close-up of fingernails
- Scalp/hair density (if willing)

[Upload interface with privacy notice]

**Privacy notice:** Photos are optional and will be de-identified. Only use photos if you consent to their use in research.

---

## Data Analysis Plan

### Primary Outcome Measures

1. **Hair growth rate:** Proportion reporting "about the same" or "faster" vs "slower"
2. **Nail growth rate:** Proportion reporting "about the same" or "faster" vs "slower"
3. **Hair/nail quality:** Composite score from thickness, strength, appearance questions

### Comparison Groups

- **ME/CFS vs healthy controls:** Expect NO difference (hypothesis prediction)
- **ME/CFS severity stratification:** Expect NO correlation between severity and hair/nail health
- **ME/CFS vs depression controls:** Differentiate energy dysfunction from psychological factors
- **ME/CFS vs autoimmune controls:** Control for inflammation effects

### Secondary Analyses

1. **Correlation analysis:** Hair/nail health vs:
   - Disease severity (Bell Scale)
   - Disease duration
   - Cognitive impairment severity
   - Exercise intolerance severity
   - PEM severity

2. **Subgroup analysis:**
   - By ME/CFS subtype (if identifiable)
   - By comorbidities
   - By nutritional status (excluding malnourished patients)
   - By age/hormonal status

3. **Confounding factor adjustment:**
   - Exclude patients with known confounders (thyroid disease, nutritional deficiency, chemotherapy)
   - Sensitivity analysis with/without these exclusions

### Statistical Methods

- **Descriptive statistics:** Frequencies, proportions, means
- **Group comparisons:** Chi-square for categorical, t-test/ANOVA for continuous
- **Correlation:** Spearman's rho for severity correlations
- **Multivariate:** Logistic regression adjusting for age, sex, disease duration, nutritional status

### Hypothesis Testing

**Null hypothesis:** ME/CFS patients have slower hair/nail growth than controls

**Alternative hypothesis (selective dysfunction model):** ME/CFS patients have preserved hair/nail growth despite severe impairment in CNS-dependent functions

**Predicted results if hypothesis TRUE:**
- Hair/nail growth: ME/CFS â‰ˆ healthy controls
- Hair/nail growth: NO correlation with disease severity
- Hair/nail health: Preserved even in severe/very severe patients
- Contrast: Muscle strength, cognition, exercise capacity all impaired

**Predicted results if hypothesis FALSE:**
- Hair/nail growth: ME/CFS < healthy controls
- Hair/nail growth: Negative correlation with severity
- Hair/nail health: Impaired proportionally to other systems

---

## Implementation Considerations

### Recruitment Strategy

**Target sample size:**
- ME/CFS cohort: n=200 minimum (50 mild, 50 moderate, 50 severe, 50 very severe)
- Healthy controls: n=100
- Disease controls: n=50 each (depression, autoimmune)

**Recruitment channels:**
- ME/CFS advocacy organizations (ME Action, Phoenix Rising, etc.)
- Specialized ME/CFS clinics
- Online patient communities (with moderator approval)
- Social media (ME/CFS hashtags)
- Research registries (MEandYou, UK ME Biobank, etc.)

### Quality Control

**Validation checks:**
- Response time (flag <2 min or >60 min as potential quality issues)
- Internal consistency (contradictory responses)
- Free text review for misunderstanding of questions

**Pilot phase:**
- 10-20 patients complete survey
- Cognitive interview: "What did you understand this question to mean?"
- Revise ambiguous questions
- Test readability score (target: 8th grade reading level)

### Ethical Considerations

**Informed consent:**
- Clear explanation that survey is for research
- Right to withdraw at any time
- Data use and privacy protections
- No compensation required (but consider small thank-you gift)

**Sensitive topics:**
- Acknowledge that hair loss can be emotionally difficult
- Option to skip questions if distressing
- Provide resources for body image support if needed

**Accessibility:**
- Screen reader compatible
- Option for caregiver assistance
- Simple language, no medical jargon
- Estimated time prominently displayed

---

## Validation and Limitations

### Potential Biases

1. **Recall bias:** Patients may not accurately remember pre-illness hair/nail status
   - *Mitigation:* Include "don't know" option, compare to age-matched controls

2. **Selection bias:** Patients with hair loss may be more/less likely to respond
   - *Mitigation:* Recruit from diverse channels, not just hair-focused forums

3. **Confounding:** Thyroid disease, nutritional deficiencies very common in ME/CFS
   - *Mitigation:* Collect detailed confounder data, perform sensitivity analyses

4. **Subjective assessment:** Self-report may not match objective measures
   - *Mitigation:* Request objective measurements where available, optional photo uploads

### Strengthening the Study

**Objective measurements substudy:**
- Recruit subset willing to measure hair/nail growth prospectively
- Provide standardized instructions and measurement tools
- Track growth over 3-6 months

**Biomarker correlation:**
- Partner with biobank studies
- Link survey responses to hair follicle biopsy data (mitochondrial function)
- Test prediction: follicle mitochondria should be normal

**Longitudinal component:**
- Re-survey subset at 6 and 12 months
- Track changes with disease severity
- Test prediction: hair/nail should remain stable even if ME/CFS worsens

---

## Expected Results and Interpretation

### If Hypothesis Supported

**Expected pattern:**
- Hair/nail growth: **Preserved** (similar to controls)
- Hair/nail quality: **Normal or near-normal** even in severe ME/CFS
- **No correlation** between hair/nail health and disease severity
- **Strong contrast** to impaired muscle, cognitive, autonomic function

**Interpretation:**
- Supports selective dysfunction model
- Autonomous peripheral processes spared
- CNS-dependent processes preferentially affected
- Implicates brain/coordination as primary dysfunction

**Clinical implications:**
- Hair/nail health should NOT be used as severity indicator
- Focus treatment on CNS energy support
- Brain-centric interventions may have broader benefits

### If Hypothesis Refuted

**Pattern if global dysfunction:**
- Hair/nail growth: **Impaired** proportionally to disease severity
- Quality: **Decreases** with worsening ME/CFS
- **Strong correlation** between hair/nail and other systems

**Interpretation:**
- Global cellular energy failure, not selective
- All high-energy processes affected equally
- Mitochondrial dysfunction is systemic
- Brain symptoms are one manifestation among many

**Clinical implications:**
- System-wide mitochondrial support needed
- No specific CNS targeting advantage
- Hair/nail changes could be biomarkers of severity

### Null Results

**No clear pattern:**
- High heterogeneity, no consistent trend
- May indicate ME/CFS subtypes with different patterns
- Some patients show preserved hair/nails, others don't

**Interpretation:**
- Supports disease heterogeneity
- Multiple pathophysiological mechanisms
- Selective dysfunction may apply to subset only
- Need for subtype-specific analysis

---

## Next Steps

### Immediate (Survey Deployment)

1. Finalize survey instrument based on this draft
2. IRB approval (if academic study) or ethics review
3. Pilot with 10-20 patients
4. Revise based on pilot feedback
5. Launch survey with recruitment campaign

### Short-term (Data Analysis)

1. Collect responses (target: 3-6 months recruitment)
2. Clean and validate data
3. Perform statistical analyses
4. Write up results
5. Submit to peer-reviewed journal

### Long-term (Follow-up Studies)

1. Objective measurement substudy
2. Hair follicle biopsy correlation
3. Longitudinal tracking
4. Integration with biomarker studies
5. Expand to other "autonomous" functions (wound healing, skin barrier, etc.)

---

## References to Integrate

- Nakatomi et al. (2014) - Neuroinflammation PET evidence
- Van Campen et al. (2024) - CBF reduction during orthostatic challenge
- Walitt et al. (2024) - NIH deep phenotyping, catecholamine deficiency
- Hair follicle biology literature (normal growth rates, regulation)
- Nail growth physiology literature
- ME/CFS severity scales (Bell, ICC functional capacity)

---

**Version:** 1.0
**Last Updated:** 2026-02-04
**Contact:** [To be added]
**License:** [To be determined - likely CC-BY for open science]